Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. (2026). Nigerian Journal of Physiological Sciences, 40(2). https://doi.org/10.54548/